Adeno‐associated viral vectored delivery of a monoclonal antibody gene against blood‐stage malaria by Bardelli, M, Alanine, D, Donnellan, F, Quinkert, D, Marshall, J, Draper, S

Adeno-associated viral vectored delivery of a novel monoclonal antibody gene against blood-stage Plasmodium falciparum malaria by Bardelli, M, Quinkert, D, Marshall, JM, Alanine, DGW, Donnellan, F, Draper, SJ

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5 by Harrison, TE, Alam, N, Farrell, B, Quinkert, D, Lias, AM, King, LDW, Barfod, LK, Draper, SJ, Campeotto, I, Higgins, MK

APC-targeted DNA vaccination against reticulocyte-binding protein homolog 5 induces plasmodium falciparum-specific neutralizing antibodies and t-cell responses by Bjerkan, L, Visweswaran, GRR, Gudjonsson, A, Labbé, GM, Quinkert, D, Pattinson, DJ, Spång, HCL, Draper, SJ, Bogen, B, Braathen, R

The structure of the cysteine-rich domain of Plasmodium falciparum P113 identifies the location of the RH5 binding site by Campeotto, I, Galaway, F, Mehmood, S, Barfod, LK, Quinkert, D, Kotraiah, V, Phares, TW, Wright, KE, Snijders, AP, Draper, SJ, Higgins, MK, Wright, GJ

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites by Weiss, GE, Ragotte, RJ, Quinkert, D, Lias, AM, Dans, MG, Boulet, C, Looker, O, Ventura, OD, Williams, BG, Crabb, BS, Draper, SJ, Gilson, PR

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host–pathogen interactions by Segireddy, RR, Belda, H, Yang, ASP, Dundas, K, Knoeckel, J, Galaway, F, Wood, L, Quinkert, D, Knuepfer, E, Treeck, M, Wright, GJ, Douglas, AD

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development by Mertens, JE, Rigby, CA, Bardelli, M, Quinkert, D, Hou, MM, Diouf, A, Silk, SE, Chitnis, CE, Minassian, AM, Moon, RW, Long, CA, Draper, SJ, Miura, K

Erythroferrone inhibits the induction of hepcidin by BMP6 by Arezes, J, Foy, N, McHugh, K, Sawant, A, Quinkert, D, Terraube, V, Brinth, A, Tam, M, Lavallie, E, Taylor, S, Armitage, A, Pasricha, S, Cunningham, O, Lambert, M, Draper, S, Jasuja, R, Drakesmith, H

Heterotypic interactions drive antibody synergy against a malaria vaccine candidate by Ragotte, RJ, Pulido, D, Lias, AM, Quinkert, D, Alanine, DGW, Jamwal, A, Davies, H, Nacer, A, Lowe, ED, Grime, GW, Illingworth, JJ, Donat, RF, Garman, EF, Bowyer, PW, Higgins, MK, Draper, SJ

Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies by Nacer, A, Kivi, G, Pert, R, Juronen, E, Holenya, P, Aliprandini, E, Amino, R, Silvie, O, Quinkert, D, Le Duff, Y, Hurley, M, Reimer, U, Tover, A, Draper, SJ, Gilbert, S, Ho, MM, Bowyer, PW

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia by Arezes, J, Foy, N, McHugh, K, Quinkert, D, Benard, S, Sawant, A, Frost, J, Armitage, A, Pasricha, S, Lim, P, Tam, M, Lavallie, E, Pittman, D, Cunningham, O, Lambert, M, Murphy, J, Draper, S, Jasuja, R, Drakesmith, A

Functional comparison of blood-stage plasmodium falciparum malaria vaccine candidate antigens by Illingworth, JJ, Alanine, DG, Brown, R, Marshall, JM, Bartlett, HE, Silk, SE, Labbé, GM, Quinkert, D, Cho, JS, Wendler, JP, Pattinson, DJ, Barfod, L, Douglas, AD, Shea, MW, Wright, KE, De Cassan, SC, Higgins, MK, Draper, SJ

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody by Rawlinson, TA, Barber, NM, Mohring, F, Cho, JS, Kosaisavee, V, Gérard, SF, Alanine, DGW, Labbé, GM, Elias, SC, Silk, SE, Quinkert, D, Jin, J, Marshall, JM, Payne, RO, Minassian, AM, Russell, B, Rénia, L, Nosten, FH, Moon, RW, Higgins, MK, Draper, SJ

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: safety and parasite growth dynamics by Salkeld, J, Themistocleous, Y, Barrett, JR, Mitton, CH, Rawlinson, TA, Payne, RO, Hou, MM, Khozoee, B, Edwards, NJ, Nielsen, CM, Sandoval, DM, Bach, FA, Nahrendorf, W, Ramon, RL, Baker, M, Ramos-Lopez, F, Folegatti, PM, Quinkert, D, Ellis, KJ, Poulton, ID, Lawrie, AM, Cho, J-S, Nugent, FL, Spence, PJ, Silk, SE, Draper, SJ, Minassian, AM

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex by Williams, BG, King, LDW, Pulido, D, Quinkert, D, Lias, AM, Silk, SE, Ragotte, RJ, Davies, H, Barrett, JR, McHugh, K, Rigby, CA, Alanine, DGW, Barfod, L, Shea, MW, Cowley, LA, Dabbs, RA, Pattinson, DJ, Douglas, AD, Lyth, OR, Illingworth, JJ, Jin, J, Carnrot, C, Kotraiah, V, Christen, JM, Skinner, K, Higgins, MK, Draper, SJ

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial by Minassian, A, Silk, S, Poulton, I, Mitton, C, Payne, R, Rawlinson, T, Barrett, J, Baker, M, Ramon, R, Lopez, F, Edwards, N, Ellis, K, Nielsen, C, Quinkert, D, Barfod, L, Miura, K, Diouf, A, Folegatti, P, Silman, D, Datoo, M, Smith, R, Berrie, E, Morelle, D, Lievens, M, Noe, A, Diggs, C, Soisson, L, Ashfield, R, Long, C, Nugent, F, Lawrie, A, Draper, S

Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies by Alanine, DGW, Quinkert, D, Kumarasingha, R, Mehmood, S, Donnellan, FR, Minkah, NK, Dadonaite, B, Diouf, A, Galaway, F, Silk, SE, Jamwal, A, Marshall, JM, Miura, K, Foquet, L, Elias, SC, Labbé, GM, Douglas, AD, Jin, J, Payne, RO, Illingworth, JJ, Pattinson, DJ, Pulido, D, Williams, BG, De Jongh, WA, Wright, GJ, Kappe, SHI, Robinson, CV, Long, CA, Crabb, BS, Gilson, PR, Higgins, MK, Draper, SJ

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies by King, LDW, Pulido, D, Barrett, JR, Davies, H, Quinkert, D, Lias, AM, Silk, SE, Pattinson, DJ, Diouf, A, Williams, BG, McHugh, K, Rodrigues, A, Rigby, CA, Strazza, V, Suurbaar, J, Rees-Spear, C, Dabbs, RA, Ishizuka, AS, Zhou, Y, Gupta, G, Jin, J, Li, Y, Carnrot, C, Minassian, AM, Campeotto, I, Fleishman, SJ, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Long, CA, Miura, K, Ashfield, R, Skinner, K, Howarth, MR, Biswas, S, Draper, SJ

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype by Barrett, JR, Pipini, D, Wright, ND, Cooper, AJR, Gorini, G, Quinkert, D, Lias, AM, Davies, H, Rigby, CA, Aleshnick, M, Williams, BG, Bradshaw, WJ, Paterson, NG, Martinson, T, Kirtley, P, Picard, L, Wiggins, CD, Donnellan, FR, King, LDW, Wang, LT, Popplewell, JF, Silk, SE, de Ruiter Swain, J, Skinner, K, Kotraiah, V, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Minassian, AM, Lauffenburger, DA, Miura, K, Long, CA, Wilder, BK, Koekemoer, L, Tan, J, Nielsen, CM, McHugh, K, Draper, SJ